TNDM
TNDM
NASDAQ · Health Care

Tandem Diabetes Care Inc

$19.05
+1.40 (+7.93%)
As of Nov 7, 1:51 AM ET ·
Financial Highlights (FY 2026)
Revenue
990.94M
Net Income
-199,907,368
Gross Margin
53.8%
Profit Margin
-20.2%
Rev Growth
+8.2%
D/E Ratio
2.03
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 53.8% 53.8% 47.0% 47.0%
Operating Margin -18.4% -16.6% 15.5% 13.6%
Profit Margin -20.2% -19.2% 9.5% 12.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 990.94M 915.93M 506.05M 514.02M
Gross Profit 533.23M 492.86M 238.02M 241.76M
Operating Income -182,828,863 -152,089,820 78.47M 70.10M
Net Income -199,907,368 -166,296,913 48.01M 63.53M
Gross Margin 53.8% 53.8% 47.0% 47.0%
Operating Margin -18.4% -16.6% 15.5% 13.6%
Profit Margin -20.2% -19.2% 9.5% 12.4%
Rev Growth +8.2% +8.2% -3.6% +0.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 419.28M 419.28M 100.92M 108.12M
Total Equity 206.58M 206.58M 530.92M 572.70M
D/E Ratio 2.03 2.03 0.19 0.19
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -165,614,817 -145,423,861 116.78M 104.62M
Free Cash Flow — — 47.29M 46.73M